Literature DB >> 21149664

Chemotherapy agents in human epidermal growth factor receptor 2-positive breast cancer: time to step out of the limelight.

Nancy U Lin, Eric P Winer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21149664     DOI: 10.1200/JCO.2010.32.5290

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  1 in total

1.  Safety and efficacy of vinorelbine in combination with pertuzumab and trastuzumab for first-line treatment of patients with HER2-positive locally advanced or metastatic breast cancer: VELVET Cohort 1 final results.

Authors:  Edith A Perez; José Manuel López-Vega; Thierry Petit; Claudio Zamagni; Valerie Easton; Julia Kamber; Eleonora Restuccia; Michael Andersson
Journal:  Breast Cancer Res       Date:  2016-12-13       Impact factor: 6.466

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.